Planatome, LLC

Planatome manufactures nano-polished surgical cutting instruments using chemical mechanical planarization (CMP) technology derived from semiconductor manufacturing. The company produces surgical blades with ultra-smooth surfaces (5–20 nm average roughness versus 5,000–50,000 nm for conventional blades), reducing tissue trauma by 1,000x. Clinical evidence demonstrates accelerated healing (90% incision healing in 72 hours versus 10% with standard scalpels), 86% reduction in hypertrophic scarring in facelift applications, improved nerve recovery (25% versus 9% at 5 weeks), and reduced inflammation. The blades exhibit superior durability, reducing procedural interruptions, OR time, and inventory costs. Applications span aesthetic surgery, plastic and reconstructive surgery, otolaryngology, and general surgical procedures. The company manufactures in Arizona and completed a spinout from a parent company in 2023, securing $6 million in capital investment. Regulatory compliance includes FDA clearance and ISO 13485 certification via DQS. The platform targets surgeons and healthcare facilities seeking improved clinical outcomes and operational efficiency through precision cutting instruments.